Steven Cohen Insmed Inc Transaction History

Point72 Asset Management, L.P.

$44.6 Billion
Q2 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Insmed Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 490,667 shares of INSM stock, worth $77.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

490,667

Holding current value

$77.1 Million

% of portfolio

0.11%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$64.81 - $105.9 $31.8 Million - $52 Million	490,667 New	490,667 $49.4 Million
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $33.7 Million - $42.9 Million	-543,149 Reduced 63.28%	315,151 $23 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $18.9 Million - $59.8 Million	858,300 New	858,300 $57.5 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $317 - $430	16 New	16 $0
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $21 Million - $28.1 Million	-1,291,580 Closed	0 $0
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $4.24 Million - $5.79 Million	-249,894 Reduced 16.21%	1,291,580 $25.8 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $2.49 Million - $3.37 Million	-119,380 Reduced 7.19%	1,541,474 $33.2 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $12 Million - $18.1 Million	-703,806 Reduced 29.76%	1,660,854 $32.8 Million
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $706,368 - $973,072	-34,592 Reduced 1.44%	2,364,660 $55.6 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $30.9 Million - $39.9 Million	-1,192,736 Reduced 33.21%	2,399,252 $65.4 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $16.1 Million - $21.1 Million	716,392 Added 24.91%	3,591,988 $98.9 Million
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $39,300 - $58,552	-1,626 Reduced 0.06%	2,875,596 $81.8 Million
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $83.8 Million - $115 Million	2,597,121 Added 927.21%	2,877,222 $98 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $768,952 - $991,203	-24,450 Reduced 8.03%	280,101 $9.33 Million
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $6.83 Million - $9.07 Million	262,874 Added 630.74%	304,551 $9.79 Million
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $46.4 Million - $96.7 Million	-3,286,999 Reduced 98.75%	41,677 $1.15 Million
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $42.1 Million - $105 Million	3,087,841 Added 1282.14%	3,328,676 $53.4 Million
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $7.6 Million - $11.8 Million	-471,654 Reduced 66.2%	240,835 $5.75 Million
Q3 2019 Nov 15, 2019	SELL	$15.49 - $25.78 $538,695 - $896,551	-34,777 Reduced 4.65%	712,489 $12.6 Million
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $15.5 Million - $21.7 Million	675,166 Added 936.43%	747,266 $19.1 Million
Q1 2019 May 15, 2019	SELL	$13.91 - $31.15 $3.38 Million - $7.57 Million	-243,050 Reduced 77.12%	72,100 $2.1 Million
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $3.88 Million - $6.25 Million	-334,150 Reduced 51.46%	315,150 $4.14 Million
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $12.3 Million - $18.2 Million	649,300 New	649,300 $13.1 Million
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $2.92 Million - $3.51 Million	-110,410 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $1.28 Million - $3.45 Million	110,410	110,410 $3.45 Million

Others Institutions Holding INSM

# of Institutions

580

Shares Held

203M

Call Options Held

2.84M

Put Options Held

3.26M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $21.3B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account